Biomark Diagnostics
  • Home
  • About BioMark
    • About Us
    • BioMark Technology
    • Publications & Scientific Posters
    • Awards and Achievements
    • Strategic Collaborations
    • Cancer Education Videos
  • Oncology Platform
    • Biomark SSAT1 Assay
    • BioMark Metabolic Panel
  • Investor Relations
    • Stock Quote
    • News Releases
    • Investment Highlights
    • Corporate Presentations and Communication
  • Bio-Stream Diagnostics
    • Bio-Stream Spectral Test
  • Recent Posts
  • Info & Contact

News Releases

« Back to News

BioMark Announces Appointment of Bill Good

November 12, 2014

BIOMARK_ANNOUNCES_APPOINTMENT_OF_BILL_GOOD (PDF)

————————————————-

< BioMark Approved Listing and Commences Trading on the CSE BioMark Diagnostics, Inc. to present at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite on December 18, 2014 >

ARCHIVES

 

  • 2019 News Release
  • 2018 News Release
  • 2017 News Release
  • 2016 News Release
  • 2015 News Release
  • 2014 News Release
Further information about BioMark is available under its profile on:
SEDAR website:
http://www.sedar.com
CSE website:
http://thecse.com

Sitemap

  • Home
  • About BioMark
    • About Us
    • BioMark Technology
    • Publications & Scientific Posters
    • Awards and Achievements
    • Strategic Collaborations
    • Cancer Education Videos
  • Oncology Platform
    • Biomark SSAT1 Assay
    • BioMark Metabolic Panel
  • Investor Relations
    • Stock Quote
    • News Releases
    • Investment Highlights
    • Corporate Presentations and Communication
  • Bio-Stream Diagnostics
    • Bio-Stream Spectral Test
  • Recent Posts
  • Info & Contact

Latest Posts

  • Richmond company looking for ‘holy grail’ in COVID-19 testing
  • Dr. Horacio Bach – receives major grant from CIHR for COVID-19 antibody development
  • BIOMARK’S LIQUID BIOPSY SCIENTIFIC PAPER TO BE FEATURED AS COVER ON CANCERS UPCOMING ISSUE
  • National research team targets glioblastoma
  • BIOMARK’S ABSTRACT FOR 2019 ASCO ONLINE PUBLICATION

Site Policies

  • Terms and Conditions
  • Website and Privacy Policy

Contact Us

INVESTOR CORPORATE INQUIRES

RASHID A. BUX
  • CEO
  • 604.370.0779
  • info@biomarkdiagnostics.com

Copyright © 2019 BioMark Diagnostics Inc. All rights reserved.

Biomark Diagnostics

BioMark's mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.